Can Cabot (CBT) Justify Its Valuation Following Weaker Earnings And A CEO Transition?

Cabot Corporation

Cabot Corporation

CBT

0.00

Cabot (CBT) has drawn investor attention after third quarter earnings on 3 August 2026 showed sharply lower net income and earnings per share, along with previously announced leadership changes at the top of the company.

Cabot's recent earnings miss and upcoming CEO transition sit against a share price that has climbed 30.68% year to date, with a 5 year total shareholder return of 77.28%. This suggests longer term momentum has been stronger than the shorter term pullback.

If this mix of earnings pressure and leadership change has you thinking about where else capital could work, it may be worth scanning opportunities through our 19 top founder-led companies

Cabot now trades only slightly below the average analyst target, even after a sharp earnings reset. The valuation question is where fair value really sits within that tight band between the recent price and published estimates.

Most Popular Narrative: 1% Undervalued

Cabot's last close at $87.62 sits just below the most followed fair value estimate of $88.50, which is built using a 7.67% discount rate and detailed long term earnings assumptions.

The analysts have a consensus price target of $88.5 for Cabot based on their expectations of its future earnings growth, profit margins and other risk factors.

However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $102.0, and the most bearish reporting a price target of just $70.0.

Read the complete narrative. Read the complete narrative.

This narrative is based on a steady lift in revenue, a bigger profit margin profile and a future earnings multiple that sits well below many chemicals peers. It may be useful to review which specific growth and margin paths have been plugged in, and how much buybacks are expected to tighten the share count over time.

Result: Fair Value of $88.50 (ABOUT RIGHT)

However, Cabot's dependence on carbon black and the execution risk in scaling battery materials mean that weaker demand or a slower ramp up could challenge this fair value story.

Another View: Cabot Through The SWS DCF Lens

While the popular fair value narrative for Cabot centers on analyst targets around $88.50, the SWS DCF model presents a slightly different perspective. On this framework, Cabot at $87.62 sits just above an estimated future cash flow value of $87.52. This suggests a market price that already reflects much of the modeled cash generation. The key question for you is whether the cash flow path in that model feels conservative or generous.

CBT Discounted Cash Flow as at Aug 2026
CBT Discounted Cash Flow as at Aug 2026

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Cabot for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

If the mixed signals around Cabot leave you uncertain, it helps to move quickly from headline reactions to your own grounded view. Start by weighing both sides of the story with the 4 key rewards and 2 important warning signs

Looking For More Investment Ideas Beyond Cabot?

If Cabot has sharpened your focus on where capital works hardest, do not stop here. Broader, well chosen ideas can make a real difference over time.

  • Target potential mispricings by scanning companies that pass quality checks yet still trade at undemanding valuations through our 52 high quality undervalued stocks.
  • Strengthen your income stream by reviewing stocks that appear built to sustain higher payouts using our 8 dividend fortresses.
  • Prioritise resilience by filtering for companies that combine lower risk profiles with sturdy fundamentals in our 83 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.